Pharmaceutical Inspection Machines Market Size, Share & Trends by Component ((Vision Inspection, X-Ray, Checkweigher, Metal Detector), Software), Type (Manual, Automatic), Packaging Type (Syringe, Blister, Bottle), Formulation (Parenteral, Oral) - Global Forecast to 2029
Report Code: PH 4491 Jul, 2024, by marketsandmarkets.com
Pharmaceutical Inspection Machines Market Size, Share & Trends
The size of global pharmaceutical inspection machines market in terms of revenue was estimated to be worth $0.9 billion in 2024 and is poised to reach $1.4 billion by 2029, growing at a CAGR of 7.6% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
The major factors driving the pharmaceutical inspection machines growth are increasing use of inspection machines by pharmaceutical and biotechnology companies, increasing number of inspection checkpoint mandates in pharmaceutical products, and rise in pharmaceutical outsourcing in emerging economies. Additionally, integration of technologies such as IoT, machine learning, and artificial intelligence in pharmaceutical inspection systems, further fueling market growth.
Pharmaceutical Inspection Machines Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Global Pharmaceutical inspection machines market Dynamics
Driver: Increasing number of inspection checkpoint mandates
The increase in inspection checkpoints is driven by several key factors including regulatory compliance, good manufacturing practices, quality assurance, and advancement in technology. Regulatory compliance is critical, with stringent requirements from agencies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe establish and enforce strict guidelines and regulations to ensure that pharmaceutical products meet rigorous standards of safety, efficacy, and quality before they are allowed on the market. For instance, in February 2024, USD FDA increased the number of inspections at Indian drug manufacturing units amid growing concerns over the quality of drugs.Almost 200 unannounced inspections were conducted by FDA in 2023 in India following a hiatus during the pandemic. Similarly, the domestic FDA inspections related to devices rose from 382 in the year 2021 to 935 in 2022, which marks almost 144% increase.Thorough inspection protocols are essential for regulatory compliance.
Restraint: High Initial Investment
The substantial initial investment required for pharmaceutical inspection machines poses a significant challenge to market growth. These sophisticated and automated systems demand high capital expenditure for procurement, installation, and integration into existing production lines. This financial burden is particularly daunting for small and medium-sized enterprises (SMEs), which represent a large segment of the manufacturing industry. The steep costs can deter these companies from adopting essential inspection technologies, despite their crucial role in ensuring product quality and regulatory compliance. High inspection quality requires the machine to detect not only obvious defects, such as black dots and shape abnormalities, but also critical flaws that affect functionality—like lamination tendency or coating defects—and issues affecting product identification, such as the legibility of engraving or printing.
New entrants must bear huge production costs and very low margins because new facilities cannot quickly attain economies of scale. Simultaneously, they must maintain the prices according to the prevailing market trend to sustain competition. Many pharmaceutical companies are concerned about the cost implications of introducing new technologies and processes. Several pharmaceutical companies are concerned about the financial impact. It’s been observed that the average cost of a modern vision inspection system ranges between USD 5,000 to 20,000 which covers the hardware cost, software costs, computation costs, and storage costs. Similarly, the price range of vision inspection system in India ranges from USD 48.08 to USD 0.12 million
Opportunity: Advancement in technologies such as IoT, machine learning, and artificial intelligence
The pharmaceutical inspection machines market is experiencing significant growth due to the integration of innovative technologies in the inspection systems. Another significant reason that contributes in the growth of pharmaceutical inspection machines is due to increased regulatory scrutiny on the safety and quality of manufactured products and the need to prevent financial losses from product recalls or packaging issues. The focus on optimizing production and packaging processes and reducing the reliance on re-inspection or manual inspection is driving more companies to develop cost-effective automated systems.
Several companies in the market are heavily investing in R&D to expand their product portfolios and strengthen their market positions. Technological advancements over the past five years, including improvements in sensors, CPU processing speeds, camera dynamic range and resolution, real-time object detection, color information usage, point cloud analysis, machine vision cloud computing, and computational cameras, are expected to propel the vision inspection systems forward. For instance, in Apil 2024, Cognex Corporation launched world’s first In-Sight L38 3D Vision System, which combines AI, 2D, and 3D vision technologies to solve a range of inspection and measurement applications.. Similarly in April 2023, SwitchOn (India) known for AI -based vision inspection startup, raised USD 4.2 million through a funding round, led by a Singapore-based fund in order to expand rapid growth in India, scale internationally with large enterprises, make key hires in sales and technology and also invest in research and development. High-resolution cameras and advanced X-ray detectors are now capable of capturing detailed images at higher speeds, allowing for real-time inspection and immediate feedback during the manufacturing process.
Challenge: Complexities in integrating pharmaceutical inspection machines
Inspections remain an indispensable tool of modern manufacturing to prevent equipment failures, process deviations, and quality defects. Its integration into existing manufacturing processes presents several intricate challenges that demand careful management to ensure smooth operations and enhanced productivity. There is a significant need to simplify the integration process for the different components of pharmaceutical inspection machines and the production line at the application site. For instance, the assembly instructions for the integration of machines are often significantly outdated and seldom reflect active quality alerts or engineering change orders
Ecosystem Analysis Pharmaceutical Inspection Machines Market
The inspection systems segment dominated the pharmaceutical inspection machines industry in 2023.
Based on component, the pharmaceutical inspection machines market is segmented into into inspection systems and software. The inspection systems segment is further bifurcated into vision inspection systems, X-ray inspection systems, leak detection systems, metal detectors, combination systems, checkweighers, and other inspection systems. The inspection systems segment dominated the market owing to factors such as increasing emphasis on product quality and safety, advancements in technology such as machine vision, rise in pharmaceutical production globally, adoption of automation to improve efficiency and reduce operational costs and need for efficient and reliable inspection processes to detect defects, contaminants, and ensure proper labelling.
The pharmaceutical companies is poised to exhibit substantial growth in the global pharmaceutical inspection machines industry at a significant CAGR throughout the forecast period.
Based on end user, the pharmaceutical inspection machines market is segmented into pharmaceutical companies, biotechnology companies and CROs & CDMOs. In 2023, pharmaceutical companies segment accounted for a largest share of the end user segment. Advancements in manufacturing technologies such as automation and robotics, stringent regulatory requirements for high-quality production, complexity of drug formulations and packaging and rising focus by pharmaceutical companies on innovation and expansion into new therapeutic areas and markets.
North America dominated global pharmaceutical inspection machines industry in 2023.
By region, pharmaceutical inspection machines market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America dominated the pharmaceutical inspection machines market followed by Europe. North America's dominance in the pharmaceutical inspection machines market is attributed to significant investment in research and development, high adoption of advanced technologies and presence of large number of pharmaceutical, biotechnology companies in the region.
Asia Pacific region is likely to grow at highest CAGR during the forecast period of 2024-2029. Asia Pacific's growth in the pharmaceutical inspection machines market is propelled by expanding pharmaceutical manufacturing capabilities and the rise in pharmaceutical outsourcing. Furthermore, presence of key market players in the region is likely to spur the market growth.
Source: Expert Interviews, Secondary Research, Whitepapers, Journals, Magazines, and MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Key players in the pharmaceutical inspection machines market include Körber AG (Germany), Mettler-Toledo (Switzerland), Omron Corporation (Japan), Cognex corporation (US), Stevanato Group (Italy), Antares Vision S.P.A (Italy), Syntegon Technology GmbH (Germany), Optel Group (Canada), Jekson Vision (India), ACG (India), Brevetti CEA SPA (Italy), Roquette Frères (France), Tofflon Life Science (China), Proditec (France), Wipotec Gmbh (Germany) and CMP Pharma S.R.L (Italy) among others.
Scope of the Pharmaceutical Inspection Machines Industry
|
Report Metric |
Details |
|
Market Revenue in 2024 |
$0.9 billion |
|
Projected Revenue by 2029 |
$1.4 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 7.6% |
|
Market Driver |
Increasing number of inspection checkpoint mandates |
|
Market Opportunity |
Advancement in technologies such as IoT, machine learning, and artificial intelligence |
This report categorizes the pharmaceutical inspection machines market to forecast revenue and analyze trends in each of the following submarkets:
By Component
-
Inspection Systems
-
Vision Inspection Systems
- Multifunctional Vision Systems
- Specialized Vision Systems
- Leak Detection Systems
- X-Ray Inspection Systems
- Combination Systems
- Checkweighers
- Metal Detectors
- Other Inspection Systems
-
Vision Inspection Systems
- Software
By Type
- Fully Automated Inspection Machines
- Semi-Automated Inspection Machines
- Manual Inspection Machines Antibodies
By Packaging Type
- Ampoules & Vials
- Syringes
- Blister
- Bottles
- Other Packaging Type
By Formulation
-
Oral
- Tablets & Capsules
- Oral Solution and suspensions/syrups
- Other Oral formulation
- Parenteral
- Other Formulation
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- CROs & CDMOs
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
-
Latin America
- Mexico
- Brazil
- Rest of Latin America
-
Middle East & Africa
- GCC Countries
- Rest of Middle East &AFrica
Recent Developments of Pharmaceutical Inspection Machines Industry:
- In April 2024, Cognex Corporation (US) launched its first AIN powered 3D vision system in order to solve a range of inspection and measurement applications.
- In December 2023, Körber AG (Germany) and Franz Ziel GmbH (Germany) entered into a partnership agreement in order to acquire Franz Ziel's share for expanding its market expertise in the field of cleanroom technology for the pharmaceutical and biotech industries as Framz Ziel solutions seamlessly complement Körber's offerings in inspection and packaging solutions
- In August 2023, Cognex Corporation (US) acquired Moritex Corporation (Japan), a renowned company in Machine Vision Optics components and advanced imaging solutions through an investment of over USD 275 million in order to deepen Cognex’s machine vision system in Japan.
- In February 2023, Antares Vision (Italy) and PYGSA Sistemas Y Applicaciones SL (Spain) entered into binding agreement under which Antares Vision acquired 30% stakes of PYGSA for expanding its distribution of its solutions in Spain, in all relevant sectors (Life Science, Cosmetics, Food & Beverage) and in Portugal for Food & Beverage only
Frequently Asked Questions (FAQ):
Who are the key players in the pharmaceutical inspection machines market?
Key players in the Market include Körber AG (Germany), Mettler-Toledo (Switzerland), Omron Corporation (Japan), Cognex corporation (US), Stevanato Group (Italy) and among others.
Which component segment dominates the pharmaceutical inspection machines market?
The inspection machines systems segment accounted for the largest share of the market in 2023. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS (Page No. - 61)
4.1 PHARMACEUTICAL INSPECTION MACHINES MARKET OVERVIEW
4.2 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE AND COUNTRY (2023)
4.3 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024 VS. 2029
4.4 PHARMACEUTICAL INSPECTION MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW (Page No. - 65)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing use of inspection machines by pharmaceutical and biotechnology companies
5.2.1.2 Rising number of inspection checkpoint mandates
5.2.1.3 Technological advancements and stringent regulatory mandates for high-quality products
5.2.2 RESTRAINTS
5.2.2.1 High initial capital expenditure and recurring maintenance costs
5.2.2.2 Increased data security and privacy concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing outsourcing of manufacturing operations to emerging economies
5.2.3.2 Focus on production optimization and high R&D investments
5.2.4 CHALLENGES
5.2.4.1 Complexities in integrating pharmaceutical inspection machines
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Machine vision technology
5.4.1.2 X-ray inspection technology
5.4.1.3 Laser inspection technology
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Advanced sensors and imaging techniques
5.4.2.2 Robotics and automation
5.4.2.3 Artificial intelligence
5.5 PRICING ANALYSIS
5.5.1 AVERAGE PRICING ANALYSIS FOR INSPECTION MACHINES, BY COMPONENT
5.5.2 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL INSPECTION MACHINES, BY REGION
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.7.1 ROLE IN SUPPLY CHAIN
5.8 ECOSYSTEM ANALYSIS
5.8.1 PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS
5.8.2 END USERS
5.8.3 REGULATORY BODIES
5.9 PATENT ANALYSIS
5.9.1 METHODOLOGY
5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014–2024
5.9.3 INNOVATION AND PATENT APPLICATION
5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180)
5.10.2 EXPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180)
5.10.3 IMPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190)
5.10.4 EXPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190)
5.11 KEY CONFERENCES AND EVENTS, 2024–2025
5.12 REGULATORY LANDSCAPE
5.12.1 CDRH REGULATIONS ON PHARMACEUTICAL INSPECTION MACHINES
5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12.2.1 North America: List of regulatory bodies, government agencies, and other organizations
5.12.2.2 Europe: List of regulatory bodies, government agencies, and other organizations
5.12.2.3 Asia Pacific: List of regulatory bodies, government agencies, and other organizations
5.12.2.4 Rest of the World: List of regulatory bodies, government agencies, and other organizations
5.13 INVESTMENT AND FUNDING SCENARIO
5.14 PORTER’S FIVE FORCES ANALYSIS
5.14.1 THREAT OF NEW ENTRANTS
5.14.2 THREAT OF SUBSTITUTES
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 BARGAINING POWER OF SUPPLIERS
5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS
5.15.2 KEY BUYING CRITERIA
6 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT (Page No. - 103)
6.1 INTRODUCTION
6.2 PHARMACEUTICAL INSPECTION SYSTEMS
6.2.1 VISION INSPECTION SYSTEMS
6.2.1.1 Multifunctional vision inspection systems
6.2.1.1.1 Versatility and improved production efficiency to drive segment
6.2.1.2 Specialized vision inspection systems
6.2.1.2.1 Stringent quality standards and better patient well-being to propel segment growth
6.2.2 X-RAY INSPECTION SYSTEMS
6.2.2.1 Increasing demand for precise underfill and overfill inspection to aid market growth
6.2.3 LEAK DETECTION SYSTEMS
6.2.3.1 Rising adoption in pharmaceutical applications to drive market growth
6.2.4 METAL DETECTORS
6.2.4.1 Growing need for metal contaminant detection in food & beverage industry to boost demand
6.2.5 CHECKWEIGHERS
6.2.5.1 Increased focus on reducing waste in manufacturing process to aid market growth
6.2.6 COMBINATION SYSTEMS
6.2.6.1 Technological advancements for ensuring thorough quality assessment and regulatory compliance to drive market
6.2.7 OTHER PHARMACEUTICAL INSPECTION SYSTEMS
6.3 PHARMACEUTICAL INSPECTION SOFTWARE
6.3.1 RISING NEED TO IMPROVE INSPECTION EFFICIENCY TO PROPEL ADOPTION
7 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE (Page No. - 147)
7.1 INTRODUCTION
7.2 FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES
7.2.1 SUPERIOR THROUGHPUT RATES AND DEFECT DETECTION ACCURACY IN HIGH-VISCOSITY SUSPENSIONS TO DRIVE MARKET
7.3 SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES
7.3.1 SIMULTANEOUS INSPECTION CAPABILITIES WITH HIGH STANDARDS OF PHARMACEUTICAL QUALITY CONTROL TO AID MARKET GROWTH
7.4 MANUAL PHARMACEUTICAL INSPECTION MACHINES
7.4.1 COST-EFFECTIVENESS TO AUGMENT SEGMENT GROWTH
8 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE (Page No. - 160)
8.1 INTRODUCTION
8.2 AMPOULES & VIALS
8.2.1 INCREASING DEMAND FOR VACCINES AND BIOPHARMACEUTICALS TO FUEL MARKET GROWTH
8.3 SYRINGES
8.3.1 IMPROVED SAFETY AND INCREASED COMPLIANCE WITH CGMP STANDARDS TO SUPPORT MARKET GROWTH
8.4 BOTTLES
8.4.1 RISING DEMAND FOR LIQUID OR SOLID RESIDUE DETECTION TO AUGMENT MARKET GROWTH
8.5 BLISTERS
8.5.1 SUPERIOR PRODUCT PROTECTION AND ENHANCED PATIENT COMPLIANCE TO BOOST MARKET GROWTH
8.6 OTHER PACKAGING TYPES
9 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION (Page No. - 178)
9.1 INTRODUCTION
9.2 ORAL FORMULATIONS
9.2.1 TABLETS & CAPSULES
9.2.1.1 Increasing applications in pharmaceutical industry to drive segment
9.2.2 ORAL SOLUTIONS & SUSPENSIONS/SYRUPS
9.2.2.1 Focus on improved product quality and prevention of contamination to fuel segment growth
9.2.3 OTHER ORAL FORMULATIONS
9.3 PARENTERAL FORMULATIONS
9.3.1 INCREASED PRODUCTION THROUGHPUT AND REDUCED HUMAN ERRORS TO BOOST SEGMENT GROWTH
9.4 OTHER FORMULATIONS
10 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER (Page No. - 200)
10.1 INTRODUCTION
10.2 PHARMACEUTICAL COMPANIES
10.2.1 HIGH PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
10.3 BIOTECHNOLOGY COMPANIES
10.3.1 FOCUS ON REDUCING COUNTERFEIT DRUG PRODUCTION AND IMPROVING PRODUCT QUALITY TO SPUR MARKET GROWTH
10.4 CROS & CDMOS
10.4.1 LOW MANUFACTURING COSTS AND HIGH-QUALITY MAINTENANCE TO FUEL MARKET GROWTH
11 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION (Page No. - 213)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US to dominate North American pharmaceutical inspection machines market during forecast period
11.2.2 CANADA
11.2.2.1 Focus on better healthcare quality and increased patient safety to support market growth
11.2.3 NORTH AMERICA: RECESSION IMPACT
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 High healthcare spending and presence of key pharmaceutical manufacturers to aid market growth
11.3.2 UK
11.3.2.1 Rising demand for personalized medicines and increasing geriatric population to augment market growth
11.3.3 FRANCE
11.3.3.1 Growth in generic drug market and increased pharmaceutical exports to spur adoption
11.3.4 ITALY
11.3.4.1 Favorable government initiatives and increased private investments to drive market
11.3.5 SPAIN
11.3.5.1 Improved healthcare infrastructure and high prevalence of chronic diseases to boost market growth
11.3.6 REST OF EUROPE
11.3.7 EUROPE: RECESSION IMPACT
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Increased investment in healthcare infrastructure to propel market growth
11.4.2 JAPAN
11.4.2.1 Well-developed pharmaceutical manufacturing industry and stringent healthcare regulations to drive market
11.4.3 INDIA
11.4.3.1 Growing focus on cost-effective branded drug production to fuel market growth
11.4.4 AUSTRALIA
11.4.4.1 High R&D expenditure and technological advancements to fuel market growth
11.4.5 SOUTH KOREA
11.4.5.1 Attractive medical tourism industry and favorable government policies to propel market growth
11.4.6 REST OF ASIA PACIFIC
11.4.7 ASIA PACIFIC: RECESSION IMPACT
11.5 LATIN AMERICA
11.5.1 BRAZIL
11.5.1.1 Increasing geriatric population and rising per capita income to aid market growth
11.5.2 MEXICO
11.5.2.1 Improving healthcare infrastructure and burgeoning pharmaceutical industry to augment market growth
11.5.3 REST OF LATIN AMERICA
11.5.4 LATIN AMERICA: RECESSION IMPACT
11.6 MIDDLE EAST & AFRICA
11.6.1 GCC COUNTRIES
11.6.1.1 Robust economic growth and high public healthcare spending to support market growth
11.6.2 REST OF MIDDLE EAST & AFRICA
11.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT
12 COMPETITIVE LANDSCAPE (Page No. - 327)
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Component footprint
12.5.5.3 Type footprint
12.5.5.4 Packaging type footprint
12.5.5.5 Region footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 VALUATION & FINANCIAL METRICS
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES (Page No. - 348)
13.1 KEY PLAYERS
13.1.1 KÖRBER AG
13.1.1.1 Business overview
13.1.1.2 Products/Services/Solutions offered
13.1.1.3 Recent developments
13.1.1.3.1 Deals
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 METTLER TOLEDO
13.1.2.1 Business overview
13.1.2.2 Products/Services/Solutions offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches
13.1.2.3.2 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Key strengths
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 OMRON CORPORATION
13.1.3.1 Business overview
13.1.3.2 Products/Services/Solutions offered
13.1.3.3 MnM view
13.1.3.3.1 Key strengths
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses & competitive threats
13.1.4 COGNEX CORPORATION
13.1.4.1 Business overview
13.1.4.2 Products/Services/Solutions offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches
13.1.4.3.2 Deals
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 STEVANATO GROUP
13.1.5.1 Business overview
13.1.5.2 Products/Services/Solutions offered
13.1.5.3 Recent developments
13.1.5.3.1 Product launches
13.1.5.4 MnM view
13.1.5.4.1 Key strengths
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 ANTARES VISION S.P.A
13.1.6.1 Business overview
13.1.6.2 Products/Services/Solutions offered
13.1.6.3 Recent developments
13.1.6.3.1 Deals
13.1.7 OPTEL GROUP
13.1.7.1 Business overview
13.1.7.2 Products/Services/Solutions offered
13.1.8 SYNTEGON TECHNOLOGY GMBH
13.1.8.1 Business overview
13.1.8.2 Products/Services/Solutions offered
13.1.8.3 Recent developments
13.1.8.3.1 Product launches
13.1.9 JEKSON VISION
13.1.9.1 Business overview
13.1.9.2 Products/Services/Solutions offered
13.1.10 ACG
13.1.10.1 Business overview
13.1.10.2 Products/Services/Solutions offered
13.1.11 BREVETTI CEA SPA
13.1.11.1 Business overview
13.1.11.2 Products/Services/Solutions offered
13.1.11.3 Recent developments
13.1.11.3.1 Deals
13.1.12 ROQUETTE FRÈRES
13.1.12.1 Business overview
13.1.12.2 Products/Services/Solutions offered
13.1.13 TOFFLON LIFE SCIENCE
13.1.13.1 Business overview
13.1.13.2 Products/Services/Solutions offered
13.1.14 PRODITEC
13.1.14.1 Business overview
13.1.14.2 Products/Services/Solutions offered
13.1.15 WIPOTEC GMBH
13.1.15.1 Business overview
13.1.15.2 Products/Services/Solutions offered
13.1.16 CMP PHARMA S.R.L.
13.1.16.1 Business overview
13.1.16.2 Products/Services/Solutions offered
13.1.16.3 Recent developments
13.1.16.3.1 Expansions
13.2 OTHER PLAYERS
13.2.1 KEYENCE CORPORATION
13.2.2 CASSEL MESSTECHNIK GMBH
13.2.3 THERMO FISHER SCIENTIFIC INC.
13.2.4 LOMA SYSTEMS
13.2.5 VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH
13.2.6 MINEBEA INTEC GMBH
13.2.7 MARCHESINI GROUP S.P.A.
13.2.8 N.K.P. PHARMA PVT. LTD.
13.2.9 SPAN SYSTEMS
14 APPENDIX (Page No. - 412)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
LIST OF TABLES (465 TABLES)
TABLE 1 PHARMACEUTICAL INSPECTION MACHINES MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 3 AVERAGE PRICING ANALYSIS FOR INSPECTION MACHINES, BY COMPONENT, 2021–2023
TABLE 4 PHARMACEUTICAL INSPECTION MACHINES MARKET: ROLE IN SUPPLY CHAIN
TABLE 5 PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS: ROLE IN ECOSYSTEM
TABLE 6 END USERS: ROLE IN ECOSYSTEM
TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, 2014–2024
TABLE 9 PHARMACEUTICAL INSPECTION MACHINES MARKET: TOP 12 PATENT OWNERS IN US, 2014–2024
TABLE 10 KEY PATENTS IN PHARMACEUTICAL INSPECTION MACHINES MARKET (2023)
TABLE 11 IMPORT VOLUME FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180), 2019–2023 (TONS)
TABLE 12 EXPORT VOLUME FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180), 2019–2023 (TONS)
TABLE 13 IMPORT VOLUME FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190), 2019–2023 (USD)
TABLE 14 EXPORT VOLUME FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE-903190), 2019–2023 (USD)
TABLE 15 PHARMACEUTICAL INSPECTION MACHINES MARKET: KEY CONFERENCES & EVENTS, JANUARY 2024–DECEMBER 2025
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 PHARMACEUTICAL INSPECTION MACHINES MARKET: PORTER’S FIVE FORCES
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET
TABLE 23 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 24 PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 25 PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 26 NORTH AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 27 EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28 ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LIST OF KEY VISION INSPECTION SYSTEMS AVAILABLE IN MARKET
TABLE 32 VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 33 VISION INSPECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 NORTH AMERICA: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 EUROPE: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 40 NORTH AMERICA: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 EUROPE: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 ASIA PACIFIC: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 LATIN AMERICA: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 NORTH AMERICA: SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 EUROPE: SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 ASIA PACIFIC: SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 LATIN AMERICA: SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA: SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 LIST OF KEY X-RAY INSPECTION SYSTEMS AVAILABLE IN MARKET
TABLE 52 X-RAY INSPECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 53 NORTH AMERICA: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 EUROPE: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 ASIA PACIFIC: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 LATIN AMERICA: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 LIST OF KEY LEAK DETECTION SYSTEMS AVAILABLE IN MARKET
TABLE 59 LEAK DETECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 60 NORTH AMERICA: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 EUROPE: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 ASIA PACIFIC: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 LATIN AMERICA: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 LIST OF KEY METAL DETECTORS AVAILABLE IN MARKET
TABLE 66 METAL DETECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 67 NORTH AMERICA: METAL DETECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 EUROPE: METAL DETECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 ASIA PACIFIC: METAL DETECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 LATIN AMERICA: METAL DETECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 MIDDLE EAST & AFRICA: METAL DETECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 KEY CHECKWEIGHERS AVAILABLE IN MARKET
TABLE 73 CHECKWEIGHERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 NORTH AMERICA: CHECKWEIGHERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 EUROPE: CHECKWEIGHERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 ASIA PACIFIC: CHECKWEIGHERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 LATIN AMERICA: CHECKWEIGHERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 MIDDLE EAST & AFRICA: CHECKWEIGHERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 KEY COMBINATION SYSTEMS AVAILABLE IN MARKET
TABLE 80 COMBINATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 81 NORTH AMERICA: COMBINATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 EUROPE: COMBINATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 ASIA PACIFIC: COMBINATION SYSTEMS MARKE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 LATIN AMERICA: COMBINATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 MIDDLE EAST & AFRICA: COMBINATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 87 NORTH AMERICA: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 EUROPE: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 ASIA PACIFIC: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 LATIN AMERICA: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 KEY PHARMACEUTICAL INSPECTION SOFTWARE AVAILABLE IN MARKET
TABLE 93 PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 EUROPE: PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 LATIN AMERICA: PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 100 FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 EUROPE: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 ASIA PACIFIC: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 LATIN AMERICA: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 107 NORTH AMERICA: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 EUROPE: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 ASIA PACIFIC: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 LATIN AMERICA: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 113 NORTH AMERICA: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 EUROPE: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 ASIA PACIFIC: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 LATIN AMERICA: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 119 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY REGION, 2022–2029 (USD MILLION)
TABLE 126 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 132 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 138 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 149 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 150 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 151 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 152 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 156 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 157 TABLETS & CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 158 NORTH AMERICA: TABLETS & CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 EUROPE: TABLETS & CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 ASIA PACIFIC: TABLETS & CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 LATIN AMERICA: TABLETS & CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 MIDDLE EAST & AFRICA: TABLETS & CAPSULES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163 ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 164 NORTH AMERICA: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 EUROPE: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 ASIA PACIFIC: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 LATIN AMERICA: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 OTHER ORAL FORMULATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 170 NORTH AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 EUROPE: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 172 ASIA PACIFIC: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 LATIN AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 MIDDLE EAST & AFRICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 176 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 177 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 182 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 188 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 189 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 193 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 195 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 200 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 201 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 206 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 207 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 209 NORTH AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 210 NORTH AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 213 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 214 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 215 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 216 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 217 US: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 218 US: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 219 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 220 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 221 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 222 US: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 223 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 224 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 225 CANADA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 CANADA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 227 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 229 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 230 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 231 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 232 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 234 EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 235 EUROPE: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 236 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 238 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 239 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 240 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 241 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 242 GERMANY: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 GERMANY: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 245 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 246 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 247 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 248 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 249 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 250 UK: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 251 UK: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 252 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 253 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 254 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 255 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 256 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 257 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 258 FRANCE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 259 FRANCE: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 260 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 261 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 262 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 263 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 264 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 265 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 266 ITALY: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 267 ITALY: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 268 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 270 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 271 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 272 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 273 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 274 SPAIN: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 275 SPAIN: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 276 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 277 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 278 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 279 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 280 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 281 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 282 REST OF EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 283 REST OF EUROPE: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 284 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 285 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 286 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 287 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 288 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 289 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 290 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 291 ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 292 ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 293 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 294 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 295 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 296 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 297 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 298 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 299 CHINA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 300 CHINA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 301 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 302 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 303 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 304 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 305 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 306 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 307 JAPAN: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 308 JAPAN: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 309 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 310 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 311 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 312 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 313 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 314 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 315 INDIA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 316 INDIA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 317 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 318 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 319 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 320 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 321 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 322 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 323 AUSTRALIA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 324 AUSTRALIA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 325 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 326 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 327 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 328 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 329 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 330 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 331 SOUTH KOREA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 332 SOUTH KOREA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 333 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 334 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 335 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 336 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 338 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 339 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 REST OF ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 342 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 343 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 344 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 345 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 346 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 347 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 348 LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 349 LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 352 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 353 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 354 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 355 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 356 BRAZIL: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 357 BRAZIL: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 358 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 359 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 360 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 361 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 362 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 363 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 364 MEXICO: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 365 MEXICO: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 366 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 367 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 368 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 369 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 370 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 371 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 372 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 373 REST OF LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 374 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 375 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 376 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 377 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 379 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 380 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 381 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 382 MIDDLE EAST & AFRICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 383 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 384 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 385 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 386 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 388 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 389 GCC COUNTRIES: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 390 GCC COUNTRIES: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 391 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 392 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 393 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 394 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 395 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 396 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
TABLE 397 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 REST OF MIDDLE EAST & AFRICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 399 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 400 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)
TABLE 401 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)
TABLE 402 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 403 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 404 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 405 PHARMACEUTICAL INSPECTION MACHINES MARKET: DEGREE OF COMPETITION
TABLE 406 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPONENT FOOTPRINT
TABLE 407 PHARMACEUTICAL INSPECTION MACHINES MARKET: TYPE FOOTPRINT
TABLE 408 PHARMACEUTICAL INSPECTION MACHINES MARKET: PACKAGING TYPE FOOTPRINT
TABLE 409 PHARMACEUTICAL INSPECTION MACHINES MARKET: REGION FOOTPRINT
TABLE 410 PHARMACEUTICAL INSPECTION MACHINES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 411 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 412 PHARMACEUTICAL INSPECTION MACHINES MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 413 PHARMACEUTICAL INSPECTION MACHINES MARKET: DEALS, JANUARY 2021–MAY 2024
TABLE 414 PHARMACEUTICAL INSPECTION MACHINES MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 415 KÖRBER AG: COMPANY OVERVIEW
TABLE 416 KÖRBER AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 417 KÖRBER AG: DEALS, JANUARY 2021–MAY 2024
TABLE 418 METTLER TOLEDO: COMPANY OVERVIEW
TABLE 419 METTLER TOLEDO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 420 METTLER TOLEDO: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 421 METTLER TOLEDO: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 422 OMRON CORPORATION: COMPANY OVERVIEW
TABLE 423 OMRON CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 424 COGNEX CORPORATION: COMPANY OVERVIEW
TABLE 425 COGNEX CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 426 COGNEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 427 COGNEX CORPORATION: DEALS, JANUARY 2021–MAY 2024
TABLE 428 STEVANATO GROUP: COMPANY OVERVIEW
TABLE 429 STEVANATO GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 430 STEVANATO GROUP: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 431 ANTARES VISION S.P.A: COMPANY OVERVIEW
TABLE 432 ANTARES VISION S.P.A: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 433 ANTARES VISION S.P.A: DEALS, JANUARY 2021–MAY 2024
TABLE 434 OPTEL GROUP: COMPANY OVERVIEW
TABLE 435 OPTEL GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 436 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
TABLE 437 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 438 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 439 JEKSON VISION: COMPANY OVERVIEW
TABLE 440 JEKSON VISION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 441 ACG: COMPANY OVERVIEW
TABLE 442 ACG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 443 BREVETTI CEA SPA: COMPANY OVERVIEW
TABLE 444 BREVETTI CEA SPA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 445 BREVETTI CEA SPA: DEALS, JANUARY 2021–MAY 2024
TABLE 446 ROQUETTE FRÈRES: COMPANY OVERVIEW
TABLE 447 ROQUETTE FRÈRES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 448 TOFFLON LIFE SCIENCE: COMPANY OVERVIEW
TABLE 449 TOFFLON LIFE SCIENCE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 450 PRODITEC: COMPANY OVERVIEW
TABLE 451 PRODITEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 452 WIPOTEC GMBH: COMPANY OVERVIEW
TABLE 453 WIPOTEC GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 454 CMP PHARMA S.R.L.: COMPANY OVERVIEW
TABLE 455 CMP PHARMA S.R.L.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 456 CMP PHARMA S.R.L.: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 457 KEYENCE CORPORATION: COMPANY OVERVIEW
TABLE 458 CASSEL MESSTECHNIK GMBH: COMPANY OVERVIEW
TABLE 459 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 460 LOMA SYSTEMS: COMPANY OVERVIEW
TABLE 461 VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH: COMPANY OVERVIEW
TABLE 462 MINEBEA INTEC GMBH: COMPANY OVERVIEW
TABLE 463 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW
TABLE 464 N.K.P. PHARMA PVT. LTD.: COMPANY OVERVIEW
TABLE 465 SPAN SYSTEMS: COMPANY OVERVIEW
LIST OF FIGURES (51 FIGURES)
FIGURE 1 PHARMACEUTICAL INSPECTION MACHINES MARKET: SEGMENTS COVERED
FIGURE 2 PHARMACEUTICAL INSPECTION MACHINES MARKET: REGIONS COVERED
FIGURE 3 PHARMACEUTICAL INSPECTION MACHINES MARKET: YEARS CONSIDERED
FIGURE 4 PHARMACEUTICAL INSPECTION MACHINES MARKET: RESEARCH DESIGN
FIGURE 5 BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)
FIGURE 6 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2023)
FIGURE 7 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (2023)
FIGURE 8 FIGURE 5 ILLUSTRATIVE EXAMPLE OF KÖRBER AG: REVENUE SHARE ANALYSIS (2023)
FIGURE 9 MARKET VALIDATION FROM PRIMARY SOURCES
FIGURE 10 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 11 PHARMACEUTICAL INSPECTION MACHINES MARKET: CAGR PROJECTIONS (2024–2029)
FIGURE 12 DATA TRIANGULATION
FIGURE 13 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
FIGURE 14 PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 15 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 16 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 17 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024 VS. 2029 (USD MILLION)
FIGURE 18 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 19 PHARMACEUTICAL INSPECTION MACHINES MARKET: REGIONAL SNAPSHOT
FIGURE 20 STRINGENT INSPECTION CHECKPOINT MANDATES AND FAVORABLE REGULATORY POLICIES TO DRIVE MARKET
FIGURE 21 US AND AMPOULES & VIALS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 22 PHARMACEUTICAL INSPECTION SYSTEMS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 23 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATES DURING STUDY PERIOD
FIGURE 24 PHARMACEUTICAL INSPECTION MACHINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25 REVENUE SHIFT TOWARD KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET
FIGURE 26 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL INSPECTION MACHINES, BY REGION (USD THOUSAND)
FIGURE 27 PHARMACEUTICAL INSPECTION MACHINES MARKET: VALUE CHAIN ANALYSIS
FIGURE 28 PHARMACEUTICAL INSPECTION MACHINES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 29 PHARMACEUTICAL INSPECTION MACHINES MARKET: ECOSYSTEM MAP
FIGURE 30 NUMBER OF PATENTS GRANTED ANNUALLY, 2014–2024
FIGURE 31 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024
FIGURE 33 PHARMACEUTICAL INSPECTION MACHINES MARKET: PORTER’S FIVE FORCES
FIGURE 34 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 35 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 36 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET SNAPSHOT
FIGURE 37 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET SNAPSHOT
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET (2021–2023)
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET (2023)
FIGURE 40 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 41 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY FOOTPRINT
FIGURE 42 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 43 EV/EBITDA OF KEY PLAYERS
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS
FIGURE 45 PHARMACEUTICAL INSPECTION MACHINES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 46 KÖRBER AG: COMPANY SNAPSHOT (2023)
FIGURE 47 METTLER TOLEDO: COMPANY SNAPSHOT (2023)
FIGURE 48 OMRON CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 49 COGNEX CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 50 STEVANATO GROUP: COMPANY SNAPSHOT (2023)
FIGURE 51 ANTARES VISION S.P.A: COMPANY SNAPSHOT (2023)
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global pharmaceutical inspection machines market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the pharmaceutical inspection machines market. The secondary sources used for this study include the US Food and Drug Administration (FDA), European Medicines Agency (EMA), General Data Protection Regulation (GDPR), International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), UK Industrial Vision Association (UKIVA), Processing and Packaging Machinery Association (PPMA), Pharmaceutical Research and Manufacturers of America (PhRMA), Association for Packaging and Processing Technologies (PMMI), Association of Indian Medical Device Industry (AIMED), Japan Inspection Instruments Manufacturers’ Association (JIMA), National Institutes of Health (NIH), World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), Eurostat Annual Reports, SEC Filings, Investor Presentations, Journals, Publications from Government Sources and Professional Associations, Interviews with Experts, and MarketsandMarkets Analysis, Company Websites, Annual Reports, SEC Filings, Investor Presentations, Press Releases, Expert Interviews, and MarketsandMarkets Analysis and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global pharmaceutical inspection machines market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biotechnology industries, CMOs and CROs, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the pharmaceutical inspection machines market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive primary and secondary research.
- The revenues generated from the pharmaceutical inspection machines business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Market Size Estimation Methodology-Bottom-up approach
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach-
Data Triangulation
After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply side.
Market Definition
Pharmaceutical inspection machines are crucial components of the quality control and assurance process. End users across the pharmaceutical industry extensively utilize these machines to ensure product quality and regulatory compliance with standards such as GMP. These machines can also seamlessly integrate into different systems. These machines are designed to inspect various types of pharmaceutical products, such as tablets, capsules, vials, ampoules, and syringes, for defects and contaminants.
Key Stakeholders
- Inspection Machine Manufacturers
- Inspection Machine Software Providers
- Inspection Machine Distributors & Suppliers
- Pharmaceutical & Biotechnology Companies
- Government Associations
- Market Research & Consulting Firms
- Venture Capitalists & Investors
The main objectives of this study are as follows:
- To define, describe, and forecast the global pharmaceutical inspection machines market based on the component, type, packaging type, formulation, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
- To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall pharmaceutical inspection machines market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America and the Middle East & Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the pharmaceutical inspection machines market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographical Analysis
- Further breakdown of the Rest of Europe's pharmaceutical inspection machines market, by country
- Further breakdown of the Rest of the Asia Pacific pharmaceutical inspection machines market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Generating Response ...
Growth opportunities and latent adjacency in Pharmaceutical Inspection Machines Market